SG Americas Securities’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-80,536
Closed -$14.3M 3969
2020
Q1
$14.3M Buy
80,536
+23,984
+42% +$4.52M 0.13% 129
2019
Q4
$10.8M Sell
56,552
-207
-0.4% -$37.3K 0.1% 179
2019
Q3
$9.55M Sell
56,759
-88,445
-61% -$14.4M 0.08% 256
2019
Q2
$24.3M Sell
145,204
-51,005
-26% -$7.06M 0.17% 102
2019
Q1
$28.7M Buy
196,209
+45,029
+30% +$6.53M 0.26% 72
2018
Q4
$20.2M Sell
151,180
-2,405
-2% -$394K 0.18% 112
2018
Q3
$29.3M Buy
153,585
+108,292
+239% +$19.9M 0.22% 89
2018
Q2
$7.55M Sell
45,293
-5,307
-10% -$852K 0.07% 296
2018
Q1
$8.52M Sell
50,600
-41,231
-45% -$6.92M 0.07% 238
2017
Q4
$15M Buy
91,831
+71,530
+352% +$12.8M 0.14% 120
2017
Q3
$4.16M Sell
20,301
-34,286
-63% -$7.97M 0.04% 412
2017
Q2
$13.3M Sell
54,587
-19,323
-26% -$4.54M 0.12% 164
2017
Q1
$17.7M Buy
73,910
+15,970
+28% +$3.72M 0.16% 122
2016
Q4
$12.2M Buy
57,940
+29,009
+100% +$6.01M 0.1% 186
2016
Q3
$6.66M Buy
28,931
+18,616
+180% +$4.55M 0.07% 270
2016
Q2
$2.38M Sell
10,315
-1,504
-13% -$347K 0.02% 750
2016
Q1
$3.17M Buy
11,819
+4,499
+61% +$1.29M 0.02% 593
2015
Q4
$2.29M Sell
7,320
-364,804
-98% -$109M 0.02% 650
2015
Q3
$46.4M Buy
372,124
+322,396
+648% +$99M 0.28% 64
2015
Q2
$15.1M Buy
49,728
+22,561
+83% +$6.73M 0.1% 143
2015
Q1
$8.09M Sell
27,167
-84,765
-76% -$24.2M 0.05% 270
2014
Q4
$28.8M Buy
111,932
+87,025
+349% +$21.8M 0.14% 131
2014
Q3
$6.01M Sell
24,907
-12,974
-34% -$2.9M 0.04% 446
2014
Q2
$8.45M Sell
37,881
-126,062
-77% -$26.1M 0.05% 383
2014
Q1
$33.7M Buy
163,943
+92,356
+129% +$18.3M 0.15% 158
2013
Q4
$12M Buy
71,587
+20,353
+40% +$3.18M 0.05% 370
2013
Q3
$7.38M Sell
51,234
-95,843
-65% -$12.8M 0.03% 503
2013
Q2
$18.6M Buy
+147,077
New +$16.7M 0.09% 219

Other funds holding AGN

SG Americas Securities's AGN Position: Q2 2020 in Review

SG Americas Securities sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 80,536 shares — an estimated $14.3M sold.

SG Americas Securities first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $46.4M in Q3 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • SG Americas Securities reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • SG Americas Securities sold 80,536 Allergan plc shares in Q2 2020, an estimated $14.3M.
  • SG Americas Securities first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • SG Americas Securities's Allergan plc position peaked at $46.4M in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on SG Americas Securities's 13F filing for Q2 2020, filed 20 Jul 2020.